(Q44841338)
Statements
Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia (English)
C Crescioli
P Ferruzzi
A Caporali
M Scaltriti
R Mancina
S Gelmini
M Serio
D Villari
G B Vannelli
E Colli
L Adorini